Key Takeaways
- • Greenberg Traurig elevated Abigail X. Xu to shareholder status in its New York office, strengthening the firm's M&A and Private Equity practices with hire from Paul, Weiss.
- • Xu brings specialized experience across acquisitions, divestitures, carve-outs, equity investments, and activist defense across technology, infrastructure, energy, financial services, and insurance sectors.
- • Recent transaction experience includes Crown Castle's $8.5 billion divestiture (Fiber Solutions to Zayo Group, Small Cell business to EQT Active Core Infrastructure fund), Eaton's $9.5 billion Boyd Thermal acquisition, and GSK's $950 million 35Pharma acquisition.
- • Xu's hire reflects Greenberg Traurig's strategic expansion of its global M&A roster, particularly in New York, as the firm deepens capabilities for both buy-side and sell-side advisory across public and private companies.
- • Ejim Peter Achi, co-managing shareholder of the New York office and co-chair of Global Corporate and Private Equity practices, cited Xu's cross-industry expertise and ability to navigate complex, high-stakes transactions as critical to client value maximization.
Summary
Xu's practice encompasses acquisitions, divestitures, carve-outs, equity investments, and activist defense across multiple industries. Her recent transactions demonstrate substantial deal-making capability: she advised on Crown Castle's $8.5 billion portfolio divestiture, which included the sale of its Fiber Solutions business to Zayo Group Holdings and its Small Cell business to Arium Networks (an EQT Active Core Infrastructure fund); Eaton's $9.5 billion acquisition of Boyd Corporation's Boyd Thermal business; and GlaxoSmithKline's $950 million acquisition of 35Pharma. She has represented both public and private companies across technology, infrastructure, energy, financial services, and insurance sectors.
Ejim Peter Achi, co-managing shareholder of Greenberg Traurig's New York office and co-chair of its Global Corporate and Private Equity practices, highlighted the strategic rationale for Xu's addition, stating that her "broad-based practice" and ability to "navigate complex, high-stakes matters with clarity and precision" strengthen the firm's capacity to serve clients across evolving transaction landscapes. Achi emphasized that Xu's cross-industry perspective and dual buy-side/sell-side expertise enhance the firm's ability to provide flexible, value-maximizing advisory.
The hire underscores Greenberg Traurig's ongoing expansion of its M&A and Private Equity capabilities globally, with particular emphasis on deepening its New York roster. Xu cited the firm's business-minded approach and focus on client value maximization as factors in her lateral move from Paul, Weiss.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.